HCPCS Level II J0750: Emtricitabine/Tenofovir for HIV PrEP
HCPCS Level II code J0750 represents the FDA‑approved prescription combination of emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg, supplied orally for HIV pre-exposure prophylaxis (PrEP); the service type is oral prescription medication for HIV prevention, typically provided in outpatient clinics, primary care offices, sexual health clinics, and specialty infectious disease practices where clinicians prescribe and dispense or facilitate access to PrEP medications.
For related coverage guidance, see recent payer policy updates: Epithelial Cell Cytology in Breast Cancer Risk Assessment, Chemotherapy Observation or Inpatient Hospitalization (for New Mexico Only), Antibody-Drug Conjugates.
Customize your policy alerts
Sign up for hcpcs J0750 policy alerts
Get alerted when payer policies referencing J0750 are released or updated.
Monitor payer policy activity